![](https://lkv.biz/wp-content/uploads/2018/07/Vakalyuk_Virstyuk-200x200.jpg)
The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
I. Vakalyuk, N. Virstyuk Ivano-Frankivsk National Medical University Introduction. Today, dyslipidaemia is considered one of the main risk factors for atherosclerosis and, as a consequence, cardiovascular disease. In turn, the liver plays a leading role in the onset of atherogenic dyslipidemia and at the same time serves as the target organ, which leads to the Read More …